InvestorsHub Logo
Followers 7
Posts 650
Boards Moderated 1
Alias Born 06/02/2009

Re: sevenOdouble post# 182

Friday, 02/25/2011 2:11:07 PM

Friday, February 25, 2011 2:11:07 PM

Post# of 240
STNS Actuality, the fda response is to a stns (Pharming, STNS Dutch counter part) application for a Biologics License, and not a jump through hoops kind of a deal... see below...

>>>>>
Pharming lodged its Biologics License Application (BLA) for Rhucin to the FDA in late December and the FDA has 60 days to accept the application, triggering the start of the regulatory approval process -- a process which is likely extend into 2012.

Keegan said he expects the FDA to accept the BLA application by the end of the month, triggering a new $5 million milestone payment from Santarus.

>>>>>
Relative Article...
http://www.reuters.com/article/2011/02/22/pharming-idUSLDE71L05F20110222?feedType=RSS&feedName=companyNews&rpc=43

STNS, Yahoo.
http://finance.yahoo.com/q?s=SNTS

There's quite a bit of stuff out on stns now, but they are still struggling financially.
http://seekingalpha.com/symbol/snts



ASCO Annual Meeting, June 4-9, 2010, Chicago IL